NASDAQ:RETA Long Term Shareholder Notice: Investigation of Potential Wrongdoing at Reata Pharmaceuticals, Inc.
Certain directors of Reata Pharmaceuticals, Inc. are under investigation concerning potential breaches of fiduciary duties by certain directors of Reata Pharmaceuticals, Inc.
View full press release